+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Microrna"

Epigenetics - Global Strategic Business Report - Product Thumbnail Image

Epigenetics - Global Strategic Business Report

  • Report
  • September 2026
  • 427 Pages
  • Global
From
RNA Interference Therapy-Competitive Landscape, 2026 - Product Thumbnail Image

RNA Interference Therapy-Competitive Landscape, 2026

  • Report
  • January 2026
  • 220 Pages
  • Global
From
From
From
Gene Therapies in Ophthalmology - Competitive Landscape, 2026 - Product Thumbnail Image

Gene Therapies in Ophthalmology - Competitive Landscape, 2026

  • Report
  • January 2026
  • 280 Pages
  • Global
From
From
From
From
From
From
From
From
The Global Exosome Market: Size, Forecast, Trials, and Trends, 2024 - Product Thumbnail Image

The Global Exosome Market: Size, Forecast, Trials, and Trends, 2024

  • Report
  • September 2024
  • 351 Pages
  • Global
From
From
Loading Indicator

The MicroRNA market is a subset of the genomics industry that focuses on the study of small, non-coding RNA molecules. MicroRNAs are involved in a variety of biological processes, including gene expression, development, and disease. They are increasingly being studied as potential therapeutic targets for a variety of diseases, including cancer, cardiovascular disease, and neurological disorders. The market for microRNA-based therapeutics is growing rapidly, driven by advances in sequencing technology and the development of new delivery systems. Companies are developing a variety of products, including diagnostics, therapeutics, and research tools. Some of the major players in the microRNA market include Thermo Fisher Scientific, Illumina, Qiagen, Merck, and Novartis. Other companies, such as Exiqon, Bio-Rad, and Bio-Techne, are also active in the market. Show Less Read more